OSE Immunotherapeutics SA
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
公司地址 22, Boulevard Benoni Goullin, Nantes, FRA, 44200
電話號碼 +33 228291010
傳真號碼 --
公司網頁 http://www.ose-immuno.com
員工數量 40
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
沒有相關資料。
 
所屬ETF (更新日期: 07/03/2026 04:54)
代號 名稱 佔比% ▼ 持有日期
THWabrdn World Healthcare1.23%31/01/2026
DFAXDimensional World ex US Core Eq 2 ETF0.04%27/02/2026
DFISDimensional International Small Cap ETF0.03%27/02/2026
DFAIDimensional International Cr Eq Mkt ETF0.02%27/02/2026
DFICDimensional International Core Eq 2 ETF0.01%27/02/2026
DXIVDimensional International Vector Eq ETF<0.000001%22/01/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.